Salivary Biomarkers in Parkinson’s Disease: A Follow-Up Study
Objective: Investigate longitudinal changes in salivary levels of oligomeric and total a-synuclein (a-syn), phosphorylated-tau (p-tau), total tau, MAP-LC3, and TNFa in Parkinson’s Disease (PD) patientsAssess…Alpha-Synuclein Preformed Fibrils Increase the Frequency of CXCR3+ B-cells in Early-stage Parkinson’s Disease Patients
Objective: To investigate the effect of a-Syn Preformed Fibrils (PFF) on CXCR3 expression on B-cells in Parkinson’s Disease (PD) patients at early (E-PD, diagnosed less…Factors contributing to balance discordance and its impact on fear of falling avoidance behavior in Parkinson’s disease
Objective: To identify cognitive and psychological factors contributing to balance discordance in people with Parkinson's disease (PwPD) and examine how it is associated with fear…GPi Lesioning vs. DBS: Does Targeting the Same Structure Differently Affect Cognition in Parkinson’s Disease?
Objective: To compare the cognitive and quality of life (QoL) outcomes of GPi-DBS and GPi-RF, investigating whether lesion-based approaches pose a greater cognitive burden over…Approaches to understanding the role of STN in the development of ICD in Parkinson’s disease
Objective: The aim of this study was to identify the features of subthalamic tracts in PD patients with ICD. Background: Recurrent negative feedback loops from…Cognitive Decline in Parkinson’s Disease: A Decade-Long Registry Analysis of Prevalence and Risk Factors
Objective: This study aims to identify predictors of cognitive decline in cognitively normal Parkinson’s disease patients by analyzing the 10 years-long PD registry. Background: Cognitive…Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report
Objective: The presented case report aims to show the possible overlap between causes of neurocognitive decline and the importance of considering comorbidities when discussing anti-amyloid monoclonal…Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.
Objective: To assess the impact of genetically defined ancestry on progression of idiopathic Parkinson's Disease and evaluate the contribution of known genetic variation on any…Utilizing the Levodopa Challenge Test to Clarify Clinical Complaints Following Levodopa Administration: A Case Series
Objective: To characterize subjective clinical complaints reported by patients with Parkinson's Disease (PD) following levodopa administration and evaluate the utility of the levodopa challenge test…Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease
Objective: The aim of this study is to make a Turkish adaptation of the "Gastrointestinal Dysfunction Scale for PD (GIDS-PD)"and detect gastrointestinal symptoms at an…
- « Previous Page
- 1
- …
- 130
- 131
- 132
- 133
- 134
- …
- 181
- Next Page »